Nongwoobio Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Nongwoobio.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Food earnings growth	14.8%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

No updates

Recent updates

Looking For Steady Income For Your Dividend Portfolio? Is Nongwoobio Co., Ltd. (KOSDAQ:054050) A Good Fit?

May 04

Is Nongwoobio Co., Ltd.'s (KOSDAQ:054050) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Jan 15

Nongwoobio's (KOSDAQ:054050) Shareholders Are Down 52% On Their Shares

Dec 28

Nongwoobio (KOSDAQ:054050) Seems To Use Debt Rather Sparingly

Dec 07

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Nongwoobio has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSDAQ:A054050 - Analysts future estimates and past financials data (KRW Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2023	135,844	10,180	10,174	16,331	N/A
9/30/2023	150,834	11,176	6,535	12,407	N/A
6/30/2023	147,060	10,342	5,247	10,519	N/A
3/31/2023	146,755	8,631	5,457	11,308	N/A
12/31/2022	133,400	9,944	5,047	9,696	N/A
9/30/2022	135,271	9,996	5,412	9,961	N/A
6/30/2022	128,286	8,008	401	4,748	N/A
3/31/2022	132,085	7,820	89	3,985	N/A
12/31/2021	132,843	6,930	39	3,857	N/A
9/30/2021	130,325	7,215	-223	2,808	N/A
6/30/2021	131,650	7,735	463	3,624	N/A
3/31/2021	129,180	8,968	1,676	5,359	N/A
12/31/2020	130,030	9,400	1,548	5,989	N/A
9/30/2020	129,894	9,015	-6,355	2,066	N/A
6/30/2020	128,206	7,266	-759	7,788	N/A
3/31/2020	125,372	8,746	-5,903	2,236	N/A
12/31/2019	121,267	6,984	-8,116	304	N/A
9/30/2019	116,344	7,295	-6,935	-425	N/A
6/30/2019	111,534	9,427	-5,840	776	N/A
3/31/2019	107,819	8,299	15,762	22,147	N/A
12/31/2018	104,027	28,664	21,707	26,805	N/A
9/30/2018	107,238	29,705	23,690	27,007	N/A
6/30/2018	108,032	28,254	17,850	20,364	N/A
3/31/2018	101,968	29,130	-495	1,141	N/A
12/31/2017	104,456	9,307	-18,995	-17,093	N/A
9/30/2017	101,093	-9,390	N/A	-19,319	N/A
6/30/2017	102,357	-7,303	N/A	-15,083	N/A
3/31/2017	102,597	-9,164	N/A	-14,541	N/A
12/31/2016	103,089	-7,548	N/A	7,705	N/A
12/31/2015	98,558	16,215	N/A	4,573	N/A
9/30/2015	96,841	16,157	N/A	4,843	N/A
6/30/2015	89,054	10,221	N/A	4,329	N/A
3/31/2015	84,004	6,118	N/A	7,373	N/A
12/31/2014	87,509	12,226	N/A	12,871	N/A
9/30/2014	89,316	14,300	N/A	13,213	N/A
6/30/2014	89,757	13,682	N/A	15,796	N/A
3/31/2014	89,639	13,193	N/A	13,070	N/A
12/31/2013	83,407	11,932	N/A	N/A	N/A
9/30/2013	81,665	11,492	N/A	8,737	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A054050's forecast earnings growth is above the savings rate (2.5%).

Earnings vs Market: Insufficient data to determine if A054050's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A054050's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A054050's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A054050's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if A054050's Return on Equity is forecast to be high in 3 years time

Nongwoobio Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Recent updates

Full year 2023 earnings released: EPS: ₩635 (vs ₩620 in FY 2022)

Upcoming dividend of ₩200 per share at 2.4% yield

New minor risk - Market cap size

Full year 2022 earnings released: EPS: ₩616 (vs ₩432 in FY 2021)

Upcoming dividend of ₩200 per share

No independent directors

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

No independent directors

Upcoming dividend of ₩200 per share

Looking For Steady Income For Your Dividend Portfolio? Is Nongwoobio Co., Ltd. (KOSDAQ:054050) A Good Fit?

Full year 2020 earnings released: EPS ₩586 (vs ₩436 in FY 2019)

Nongwoobio (KOSDAQ:054050) Has A Rock Solid Balance Sheet

Our Take On The Returns On Capital At Nongwoobio (KOSDAQ:054050)

New 90-day high: ₩14,050

Know This Before Buying Nongwoobio Co., Ltd. (KOSDAQ:054050) For Its Dividend

New 90-day high: ₩13,450

Is Nongwoobio Co., Ltd.'s (KOSDAQ:054050) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Investor sentiment improved over the past week

New 90-day high: ₩10,900

Nongwoobio's (KOSDAQ:054050) Shareholders Are Down 52% On Their Shares

Upcoming Dividend of ₩200 Per Share

Nongwoobio (KOSDAQ:054050) Seems To Use Debt Rather Sparingly

New 90-day low: ₩10,000

New 90-day low: ₩10,100

New 90-day high - ₩11,900

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies